Utility of polygenic risk scores in UK cancer screening: a modelling analysis
Catherine Huntley(National Health Service), Clare Turnbull(Institute of Cancer Research), Margaret McCartney(University of St Andrews), Richard S. Houlston(Institute of Cancer Research), Rosalind Way(Institute of Cancer Research), Michael E. Jones(Institute of Cancer Research), Helen Hanson(University of Exeter), Amit Sud(Royal Marsden NHS Foundation Trust), Anneke Lucassen(Centre for Human Genetics), John Broggio(National Health Service), Charlie F Rowlands(Institute of Cancer Research), Aroon D. Hingorani(University College London Hospitals NHS Foundation Trust), Katie Snape(Institute of Cancer Research), Bethany Torr(Royal Marsden NHS Foundation Trust), Charles Swanton(The Francis Crick Institute)
Cited by 84
Related Papers
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
|The Lancet|2014|1.6k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution
|Genome biology|2016|1.3k
Treatment of Periodontitis and Endothelial Function
|New England Journal of Medicine|2007|1.3k
Large-scale genotyping identifies 41 new loci associated with breast cancer risk
|Nature Genetics|2013|1.1k